Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tarveda Therapeutics

Request full access

Developing Pentarin miniature drug conjugate medicines to make a difference in the treatment of patients with solid tumor malignancies

Watertown, United StatesFounded 2011Biotech & Life Sciences

About Tarveda Therapeutics

Tarveda Therapeutics is a biopharmaceutical company focused on developing Pentarin miniature drug conjugates to treat patients with solid tumor malignancies. These innovative medicines are designed to rapidly penetrate solid tumors, selectively bind to tumor targets, and accumulate anti-cancer payloads, enhancing the efficacy of cancer treatment. Tarveda operates in the oncology market and serves healthcare providers and patients battling solid tumors. The company generates revenue through licensing agreements, such as the one with SciClone Pharmaceuticals for PEN 866 in Greater China, and through the development and commercialization of its drug candidates. Tarveda's business model is centered on advancing its clinical programs and forming strategic partnerships to bring its therapies to market.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
69.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Oct 2021 $6M $150M Versant Ventures —
SERIES DOther financing Feb 2017 $30M $120M Novo Holdings · Flagship Pioneering · +ND Capital · NEA —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Tarveda Therapeutics website traffic

Latest recorded traffic for Tarveda Therapeutics is 1.6K monthly website visits, up 492.6% over the last three months. Tarveda Therapeutics's team declined 16.7% over the past year.

Latest monthly visits1.6K 3-month web change+492.6% 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tarveda Therapeutics in the Watertown ecosystem

Live from Dealroom

The Tarveda Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later3 investors entered at this stage

Other known investors1 additional known investor

  • Massachusetts Institute of Technology
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tarveda Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tarveda Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.